Assessing Immune Recovery After Transplant
Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.
- Age
- 16 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 456 (estimated)
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China · Other
This trial is looking for patients over 16 who have received a specific type of stem cell transplant. Participants will be monitored regularly and reminded to follow up with their healthcare team.
You may be able to join if
- I am at least 16 years old.
- I have received haploidentical allo-HSCT.
- I will sign an informed consent form before starting.
You may not be able to join if
- I have had tandem transplantation or multiple transplantations.
- I have a mental or medical condition that makes it hard to follow the study requirements.
- I have other factors that make me ineligible or would put me at great risk in the study.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityTo assess the effectiveness of interventions including health monitoring and regular return follow-up reminders for patients with a high Composite Immune Risk Score.
Loading trial locations…